A medida que ms y ms pacientes han recurrido a los medicamentos GLP-1 para perder peso, los investigadores tambin han descubierto que los GLP-1 reducen el riesgo de accidentes cerebrovasculares e infartos y ayudan con la apnea del sueo, el trastorno por consumo de sustancias y los riesgos de cncer
A phase 2, 16-week, open-label study in 18 subjects ranging from 6 to 40 years of age results in a mean BMI reduction of 18% in those younger than 18 years, and 6% for those 18 years or older, accompanied by significant reduction of hunger scores (127)
Furthermore, we will answer questions so patients understand how GLP-1 can help them achieve their weight loss goals
Off-label use in patients with metabolic syndrome and visceral adiposity is common in performance medicine practice
12 Aging, menopausal symptoms, and hormone shifts act together to discourage physical activity, increase food intake, and reduce sleep, which also promotes poor food habits, including excessive snacking